Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Binex Co Ltd (053030 KS)
Watchlist
35
Analysis
Health Care
•
South Korea
BINEX Co., Ltd. manufactures medical drugs and medical drug materials. The Company's main products include anti-cancer drugs, composite digestive enzymes, and protein activation drugs.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Danal Co Ltd
•
11 Apr 2022 15:18
KOSDAQ 150 Rebalancing in June: Safely Tradable Names for Position Buildups at This Point
This post screens the tradable stocks for Long/Short position buildups for the KOSDAQ 150 rebalancing, which will occur on the second Thursday in...
Sanghyun Park
Follow
556 Views
Share
bullish
•
GOLFZON
•
27 Mar 2022 15:21
KOSDAQ150 Index Rebalance Preview (June): Potential Inclusions Starting to Outperform
With 80% of the review period complete, there are 15 potential index changes. The potential inclusions have started to outperform the index and the...
Brian Freitas
Follow
663 Views
Share
bullish
•
WYSIWYG Studios
•
06 Jan 2022 05:08
KOSDAQ150 Index Rebalance Preview (June 2022): Lots of Changes Early in the Review Period
A third of the way through the review period, we see 14 potential changes to the KOSDAQ150 Index at the June rebalance. A reversal in performance...
Brian Freitas
Follow
698 Views
Share
bullish
•
Hana Materials Inc
•
25 May 2021 18:41
KOSDAQ150 Index Rebalance: 16 Changes & Large Turnover
There are 16 changes to the KOSDAQ150 index resulting in a one-way turnover of 7.04%. The impact on the exclusions is a lot higher than on the...
Brian Freitas
Follow
619 Views
Share
bullish
•
SK Oceanplant
•
25 May 2021 18:31
KOSDAQ 150 Rebalancing Results: Changes, Passive Flow, & Trade Approach
The KRX has just announced the results of the KOSPI 200 semi-annual rebalancing. This post examines the passive flow of the adds and deletes as...
Sanghyun Park
Follow
509 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x